Author Archives: Stephanie Audain

LUTHER W. BRADY, M.D. INDUCTED INTO THE SPANISH ROYAL ACADEMY OF MEDICINE

PHILADELPHIA, Pa. – June 15, 2016 — Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today that Luther W. Brady, M.D. is being made an Extraordinary International Academic Member of the Spanish Royal Academy of Medicine.

Dr. Brady is the founder of The CyberKnife Center of Philadelphia and the current Director of Medical Research at Philadelphia CyberKnife, an Alliance Oncology radiation therapy center. He is recognized as one of the world’s foremost experts in cancer treatment and has published more than 800 papers in peer review journals and has led numerous clinical trials. Radiation oncologists around the world are familiar with his text books and the Encyclopedia of Radiation Oncology (Brady-Yaeger Eds.). He has won over thirty medals for his contributions in medicine and has served as president of every major radiation oncology professional society.

Dr. Brady was born in North Carolina and received his undergraduate and medical degrees at George Washington University in Washington, D.C. He received post-graduate training in radiology and radiation oncology at the U.S. Naval Hospital in Bethesda, and in Philadelphia at Thomas Jefferson Medical College and the Hospital of the University of Pennsylvania. He has had appointments at the Harvard Medical School, The College of Physicians and Surgeons of Columbia University, but has spent the majority of his career in Philadelphia first at the University of Pennsylvania, and since 1959, at Hahnemann University Hospital, now Drexel University.

To be named an Extraordinary International Academic Member of the Spanish Royal Academy of Medicine, the candidate must be nominated by two full-members of the Royal Academy and the nominators must be from Complutense University, the largest university in Spain. Dr. Brady was nominated by Prof. Jose Luis Carreras, Professor of Nuclear Medicine, and Prof. Eduardo Diaz-Rubio, Professor of Medical Oncology.

The purpose of the Spanish Royal Academy of Medicine is to promote the progress of Spanish medicine, publish its historical background, and serve as a resource for medicine in Spain. The tasks and current projects of the Royal Academy include the Dictionary of Medical Terms, the announcement and awarding of Prizes, and computerization of its bibliographic material. It consists of fifty Academic Fellows and Honor Scholars, Corresponding National and Foreign Members, and Medals of Honor.

Dr. Brady will travel to Madrid to accept this honor at a ceremony held at the Royal Academy of at Medicine on Wednesday, June 22.

About Philadelphia CyberKnife

Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System, and is an Alliance Healthcare facility. The center is located off the hospital’s main campus at 2010 West Chester Pike in Havertown, Pennsylvania. For more information about Philadelphia CyberKnife, please visit www.PhillyCyberKnife.com or call (610) 446-6850. Most insurance plans and Medicare are accepted.

About Alliance HealthCare Services

Alliance HealthCare Services (NASDAQ: AIQ) is a leading national provider of outsourced healthcare services to hospitals and providers. We also operate freestanding outpatient radiology, oncology and interventional services clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by hospitals or providers. Diagnostic radiology services are delivered through the Radiology Division (Alliance HealthCare Radiology), radiation oncology services are delivered through the Oncology Division (Alliance Oncology), and interventional and pain management services are delivered through the Interventional Services Division (Alliance HealthCare Interventional Partners). Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of March 31, 2016, Alliance operated 601 diagnostic radiology and radiation therapy systems, including 117 fixed-site radiology centers across the country, and 32 radiation therapy centers and SRS facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states, where approximately 2,400 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit https://www.alliancehealthcareservices-us.com.

Photo: Luther W. Brady, M.D.

LUTHER W. BRADY, M.D. AWARDED SEVENTH HONORARY DEGREE

PHILADELPHIA, Pa. – June 7, 2016 — Greg Spurlock, President of Alliance Oncology, announced today that Luther W. Brady M.D., Director of Medical Research at The CyberKnife Center of Philadelphia, is being awarded his seventh honorary degree from Complutense University in Madrid, Spain.

Complutense University, the largest university in Spain, will make this award of an honorary Doctorate of Science degree to Dr. Brady during a special ceremony at the university. He was recommended for the honor by Prof. Dr. Felipe A. Calvo, Hospital Vice-Dean of the Medical School and Chair-Professor at Complutense University.

Dr. Brady said, “I am very pleased to receive this honorary degree from Complutense University. It always represents a humbling but rewarding experience when you are recognized for the work that you have done.”

This will be Dr. Brady’s seventh honorary degree. His six previous degrees are a Doctor of Fine Arts from Colgate University in 1988, Doctor of Science from Lehigh University in 1990, Doctor of Medicine from Toyama Medical and Pharmaceutical University in 1996, Doctor of Medicine from the University of Heidelberg in 1997, Doctor of Fine Arts from George Washington University in May 2004, and a Doctor of Fine Arts from the Pennsylvania Academy of the Fine Arts in May 2009.

Dr. Brady is the founder of The CyberKnife Center of Philadelphia and one of the most distinguished pioneers in the field of radiation oncology. He is recognized as one of the world’s foremost experts on cancer treatment and has published more than 800 papers in peer review journals and led numerous clinical trials. Virtually every radiation oncologist in the world is familiar with his text books and the Encyclopedia of Radiation Oncology (Brady-Yaeger Eds.). He has received over thirty medals for his contributions in medicine and has served as president of every major radiation oncology professional society.

Dr. Brady was born in North Carolina and received his undergraduate and medical degrees at George Washington University in Washington, D.C. He received post-graduate training in radiology and radiation oncology at the U.S. Naval Hospital in Bethesda, and in Philadelphia at Thomas Jefferson Medical College and the Hospital of the University of Pennsylvania. He has had appointments at the Harvard Medical School, The College of Physicians and Surgeons of Columbia University, but has spent the majority of his career in Philadelphia first at the University of Pennsylvania, and since 1959, at Hahnemann University Hospital, now Drexel University.

“Everyone at Alliance Oncology is proud that Dr. Brady will receive such an honor,” said Spurlock. “Dr. Brady has contributed significantly over the years to the field of radiation oncology and this recognition of his hard work and dedication is much deserved.”

About Philadelphia CyberKnife

Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System, and is an Alliance Healthcare facility. The center is located off the hospital’s main campus at 2010 West Chester Pike in Havertown, Pennsylvania. For more information about Philadelphia CyberKnife, please visit www.PhillyCyberKnife.com or call 610.446.6850. Most insurance plans and Medicare are accepted.

About Alliance HealthCare Services

Alliance HealthCare Services (NASDAQ: AIQ) is a leading national provider of outsourced healthcare services to hospitals and providers. We also operate freestanding outpatient radiology, oncology and interventional services clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by hospitals or providers. Diagnostic radiology services are delivered through the Radiology Division (Alliance HealthCare Radiology), radiation oncology services are delivered through the Oncology Division (Alliance Oncology), and interventional and pain management services are delivered through the Interventional Services Division (Alliance HealthCare Interventional Partners). Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of March 31, 2016, Alliance operated 601 diagnostic radiology and radiation therapy systems, including 117 fixed-site radiology centers across the country, and 32 radiation therapy centers and SRS facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states, where approximately 2,400 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit https://www.alliancehealthcareservices-us.com.

Photo: Luther W. Brady, M.D.

RENO CYBERKNIFE UPGRADES THEIR CYBERKNIFE® ROBOTIC RADIOSURGERY SYSTEM

NEWPORT BEACH, Calif. – April 26, 2016 – Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced radiology, oncology and interventional services, announced today that one of their radiation therapy centers, Reno CyberKnife, has upgraded their CyberKnife Robotic Radiosurgery System. The decision to upgrade the technology at the center was part of Reno CyberKnife’s commitment to ensure patients are treated with the most advanced technology available.

The CyberKnife System was upgraded from the 8.5 version to the 10.5 version, with extra features added including the Lung Optimized Treatment (LOT) function, the IRIS II, MultiPlan V5.5 TPS, and Xsight Spine Prone.

The Lung Optimized Treatment package is a suite of software that provides a complete fiducial free clinical solution for most lung cancer patients. Because fiducial implantation is no longer required, CyberKnife radiosurgery with Lung Optimized Treatment offers a completely noninvasive option, which is particularly important for medically or surgically inoperable patients. It enables physicians with greater flexibility in delivering radiosurgery treatments to patients with lung cancer, the most common and deadly cancer worldwide.

“Our CyberKnife upgrade will add versatility to our options on how we treat our lung cancer patients, allowing us individualize and optimize patient care,” said Jonathan Tay M.D., Co-Medical Director at Reno CyberKnife.

The IRIS II is a feature that will help provide a better quality treatment, as well as shorten it. The IRIS II is a variable-aperture collimator which uses two offset banks of six prismatic tungsten leaves to form a blurred regular dodecagon field of variable size which eliminates the need for changing the fixed collimators. With the new IRIS II, the CyberKnife only needs to travel around the tumor in one trip and the IRIS II can change the field sizes as needed, allowing for a short and smooth treatment. In addition, this feature grants the clinical team the choice of as many as nine various sizes of radiation beams to treat a tumor, compared to up to three sizes using fixed collimators. The extra flexibly improves the quality of treatment plans, particularly for irregular-shaped tumors.

The MultiPlan Treatment Planning System enables the clinical team (physicist, radiation oncologist and surgeon, among others) to generate high quality CyberKnife treatment plans with a stronger computation power and a better optimization algorithm. Flexible and individualized treatment plans can be created quickly and intuitively, resulting in a fast and accurate treatment delivery for the patient. Other key features of the Multiplan is that it offers remote tools that allows the physician to remotely run the MultiPlan Treatment Planning System from any location, provide enhanced communication capabilities, and give CyberKnife centers the ability to collaborate and outreach to remote facilities and physicians.

The feature of this new version of CyberKnife that has the most impact on patients is the Xsight Spine Prone. The Xsight Spine Prone tracking system provides tracking of tumors in or near the spine, allowing patients to be treated in the prone position (lying with the chest down and back up). This is wonderful news because delivering radiation to a posterior target, such as tumors in or near the spine, with the patient in the supine position (lying face up) results in a high number of monitor units per beam, which could induce a high dose of radiation to the surrounding healthy tissue. Other patient benefits of the Xsight Spine Prone include its targeting accuracy (1.5 mm), it is a noninvasive method of delivering spine radiosurgery, it is faster with less complex treatments, and it provides an additional treatment option for those who are not candidates for surgery or conventional radiation therapy.

The dedicated radiation oncologists and clinical team at Reno CyberKnife consistently strive for excellence in quality patient care and are committed to providing the best solution for each patient’s needs. With the latest version of the CyberKnife Robotic Radiosurgery System, they are well on their way to better treatment options with which to treat patients and improve their quality of life.

Reno CyberKnife is located at 645 North Arlington Ave., Ste. 120, Reno, Nev. 89503. For more information, or to make an appointment, please visit www.RenoCyberKnife.com or call (775) 348-9900.

About Alliance HealthCare Services

Alliance HealthCare Services (NASDAQ: AIQ) is a leading national provider of outsourced healthcare services to hospitals and providers. We also operate freestanding outpatient radiology, oncology and interventional services clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by hospitals or providers. Diagnostic radiology services are delivered through the Radiology Division (Alliance HealthCare Radiology), radiation oncology services are delivered through the Oncology Division (Alliance Oncology), and interventional and pain management services are delivered through the Interventional Services Division (Alliance HealthCare Interventional Partners). Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of December 31, 2015, Alliance operated 563 diagnostic radiology and radiation therapy systems, including 116 fixed-site radiology centers across the country; and 32 radiation therapy centers and SRS facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states, where approximately 2,430 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit https://www.alliancehealthcareservices-us.com.

CyberKnife-Robotic-Radiosurgery-System

Photo: The CyberKnife Robotic Radiosurgery System at Reno CyberKnife.

Alliance Oncology Announces Senior Leadership Team Additions and Promotions

NEWPORT BEACH, CA – March 1, 2016 — Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today three new changes to their senior leadership team.

“As Alliance Healthcare Services aligns itself for growth, our divisions are reviewing their strategic plans, moving to execute as quickly as possible to deliver positive results, and insuring they are structured appropriately to handle the growth within their own segment of the business,” said Greg Spurlock, President of Alliance Oncology. “Alliance Oncology is a key example of stepping forward in this growth story, structuring itself to most efficiently deliver new partnerships and opportunities.”

Alliance Oncology announced that Elizabeth Pace, MHA, has joined the company as Senior Vice President of Operations. Pace has more than 20 years of senior executive healthcare experience and is recognized for her success in developing, launching and growing business for hospital, managed care and ancillary health care services. Pace’s achievements include increased volume and market share across multiple service lines of a $1.3 billion healthcare system, leading business development in managed care startups and providing strategic consulting. Most recently, Pace was the VP of the Oncology Service Line for a nine hospital system where she was responsible for clinically integrating all cancer services including screening, diagnostics, pathology, surgical oncology, medical oncology radiation oncology and all support services. Pace earned a B.S. in Accounting from The Ohio State University and a Master’s Degree in Health Services Administration from Xavier University.

In addition to Elizabeth Pace joining the company, Alliance Oncology announced the promotions of Josh Eaves to Senior Vice President of Strategic Partner Development and Acquisitions and Tim Smith to Senior Vice President of Business Development.

Josh Eaves joined Alliance Oncology October 2006 as Vice President of Business Development, where he was responsible for the development of stereotactic radiosurgery (SRS) facilities and radiation therapy centers. Prior to joining Alliance, he held a variety of senior business development positions, including Director of Business Development for Neospine, LLC, and Director of Development for e+ Cancercare, LLC. Eaves earned a B.A. in Communications from Vanderbilt University.

Tim Smith joined Alliance Oncology April 2014 as Vice President of Business Development, where he was responsible for the development of radiosurgery facilities and radiation therapy centers. Smith’s healthcare background includes over 25 years of experience in business development, operations and marketing. Prior to joining Alliance, he served as Vice President of Health System Development for AMSURG—the nation’s largest outpatient surgery center company, and Vice President of Marketing at Clearpractice. Smith earned a B.A. in Marketing and Communications from Lipscomb University.

About Alliance HealthCare Services

Alliance HealthCare Services (NASDAQ: AIQ) is a leading national provider of outsourced healthcare services to hospitals and providers. We also operate freestanding outpatient radiology, oncology and interventional services clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by hospitals or providers. Diagnostic radiology services are delivered through the Radiology Division (Alliance HealthCare Radiology), radiation oncology services are delivered through the Oncology Division (Alliance Oncology), and interventional and pain management services are delivered through the Interventional Services Division (Alliance HealthCare Interventional Partners). Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of December 31, 2015, Alliance operated 563 diagnostic radiology and radiation therapy systems, including 116 fixed-site radiology centers across the country; and 32 radiation therapy centers and SRS facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states, where approximately 2,430 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit https://www.alliancehealthcareservices-us.com

news-senior-leadership-team